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Context. Leiomyosarcomas are rare malignant smooth muscle tumors that may arise in any organ or tissue that contains smooth
muscle, commonly within the gastrointestinal tract. They are most often found in the stomach, large and small intestines, and
retroperitoneum. Primary pancreatic leiomyosarcoma is extremely rare, and to the best of our knowledge only 30 cases have
been reported in the world literature since 1951. Our case represents the ﬁrst to have a clear origin from the main pancreatic
duct. Case Report. This case was diagnosed in a large, tertiary care center in Tampa, Florida. Pertinent information was obtained
from chart review and interdepartmental collaboration. A mass in the tail of the pancreas was identiﬁed with large pleomorphic
and spindle-shaped cells. Immunohistochemistry for vimentin, smooth muscle actin, and desmin was positive. All remaining
immunohistochemical markers performed were negative. The tumor clearly originated from the pancreatic duct wall, ﬁlled
and expanded the duct lumen, and was covered with a layer of benign biliary epithelium. Conclusion. Leiomyosarcoma of the
pancreas is an extremely rare malignancy with few reported cases in the literature. The prognosis is poor, and treatment consists of
alleviating symptoms and pain management. To our knowledge, this represents the ﬁrst reported case demonstrating clear origin
of a leiomyosarcoma from the pancreatic duct.
1.Introduction
Leiomyosarcomas are rare malignant tumors of smooth
muscle origin that may arise in any organ or tissue that
contains smooth muscle and comprise less than 1% of
all cancers and 2%–9% of sarcomas [1]. They are most
commonlyfoundinthestomachandsmallintestineandmay
also be commonly found in the large intestine, uterus, and
retroperitoneum [1]. Primary pancreatic leiomyosarcoma
is extremely rare and has seldomly been reported in the
literature. Typically the prognosis is poor, and treatment
consists of alleviating symptoms and managing discomfort
with one or more modalities including surgery, radiation,
and/or chemotherapy. This case shows a clear origination
from the pancreatic duct.
2.CaseReport
An 83-year-old woman presented with a 3-month history of
left-sided abdominal pain and weight loss. Her history was
pertinent for a total abdominal hysterectomy with bilateral
salpingo-oophorectomy in 1963 for benign leiomyomas with
dysmenorrhea, a cholecystectomy in 1978 for cholelithiasis,
and a hernia repair in 1993. No mass lesion was identiﬁed
on physical examination. Abdominal CT scan and MRI
revealed an 8 cm mass within the tail of the pancreas with
no evidence of invasion into adjacent structures. At this time
the presumed diagnosis was pancreatic adenocarcinoma.
Ultrasound-guided biopsy of the lesion was attempted but
yielded no diagnostic tissue. A distal pancreatectomy with
splenectomy was performed and revealed an intrapancreatic2 Case Reports in Medicine
Figure 1: Low power view of the tumor showing the expansion of
the duct wall with dilation of the lumen (H & E 100x).
Figure 2: High power view showing highly pleomorphic cells and
numerous/atypical mitosis (H & E 400x).
tan, nodular mass measuring 8.5 × 7.0 × 6.2cmwithfocal
hemorrhagic areas suggestive of necrosis. The margins were
grossly free of tumor. Histological examination showed large
pleomorphic and spindle-shaped cells, focal necrosis, and a
mitotic count of >20 per 10 high power ﬁelds, with negative
surgicalmargins(Figures1and2).Multiplesectionsfailedto
demonstrateamalignantepithelialcomponent.Immunohis-
tochemical analysis showed tumor cells positive for smooth
muscle actin (SMA), desmin, and vimentin and negative for
other markers performed (pan cytokeratin, c-kit, CD34, and
S-100) (Figures 3 and 4). There was a clear origination from
the pancreatic duct wall with expansion of the lumen. Based
on the histopathology and immunohistochemical proﬁle,
a diagnosis of leiomyosarcoma was rendered. The patient
decided against further treatment and at 8 months was doing
well with no apparent residual disease or metastasis.
3. Discussion
Primary pancreatic sarcomas of any type are rare although
many have been reported in the literature including
ﬁbromyxoid sarcoma, follicular dendritic cell sarcoma,
Figure 3: Smooth muscle actin immunohistochemical stain shows
positive staining in the pleomorphic and spindle tumor cells,
indicating smooth muscle origin of this lesion (100x).
Figure 4: Pan-keratin, highlighting the residual ductal epithelium
with no staining in tumor cells (100x).
Kaposi’s sarcoma, leiomyosarcoma, ﬁbrosarcoma, liposar-
coma, angiosarcoma, and rhabdomyosarcoma [2–14]. Epi-
demiologic data derived from case reports suggests that
most of the cases of primary pancreatic sarcoma occur in
patients over 50 if not over 70 years of age, except for
rhabdomyosarcoma which favors children and sometimes
young adults [8]. It has been suggested that the pancreatic
duct or blood vessel walls most likely serve as an origin for
pancreatic leiomyosarcomas, a thought that is supported by
their usual location within the body or tail [15]. Our case
represents the ﬁrst time clear origination from the pancreatic
duct wall has been shown.
Leiomyosarcomas are malignant smooth muscle neo-
plasms that can arise in any anatomic location containing
smooth muscle, most commonly the stomach, but can be
foundanywherealongthegastrointestinaltract,aswellasthe
uterusandretroperitoneum. Theyhavealsobeenreported in
theskin, bladder,ovaries, salivaryglands,larynx,gallbladder,
adrenal glands, broad ligament, diaphragm, breast, vulva,
penis, scrotum and testis, and, of course, the pancreas
[16–37]. Leiomyosarcomas are rare, comprising less than
1% of all cancers. A compilation of data on pancreaticCase Reports in Medicine 3
leiomyosarcomas presented by Aihara et al. shows an age
range of 14–80 years for initial diagnosis of pancreatic
leiomyosarcoma with a mean of 52.8 years and a median of
52.5 years [15]. Of the patients who died from pancreatic
leiomyosarcoma, mean time to death was 11.5 months with
a range of 5 days to 4 years [15]. These aggressive tumors
tend to metastasize hematogenously, most commonly to the
lung and less frequently the liver, brain, bone, spinal column,
and skin [21, 31, 38]. On histopathological examination,
malignancy is mainly determined by tumor necrosis, the
number of mitoses (generally believed to be ≥ 2/10 HPF),
atypical mitotic activity, and an inﬁltrative pattern. Most
leiomyosarcomas are immunopositive for SMA, desmin,
caldesmon, and vimentin.
4. Conclusion
Leiomyosarcoma of the pancreas is an extremely rare malig-
nancywithfewreportedcasesintheliterature.Theprognosis
is poor, and treatment consists of surgical resection with
chemotherapy and/or radiation for alleviating symptoms
and pain management. To our knowledge, this represents
the ﬁrst reported case demonstrating clear origin of a
leiomyosarcoma from the pancreatic duct.
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